𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thalidomide + dexamethasone highly promising in multiple myeloma

Book ID
120860404
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2003
Weight
151 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thalidomide–dexamethasone as primary the
Thalidomide–dexamethasone as primary therapy for advanced multiple myeloma
✍ Michael Wang; Donna M. Weber; Kay Delasalle; Raymond Alexanian 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 1 views

## Abstract The value of thalidomide–dexamethasone was assessed in 26 consecutive, previously untreated patients with multiple myeloma of high tumor mass. All showed Hgb < 8.5 g/dL, serum calcium > 11.5 mg/dL, or both. The response rate was 73%, frequency of early death < 3 months was 5%, projected

Thalidomide in multiple myeloma
Thalidomide in multiple myeloma
✍ P Richardson; T Hideshima; K Anderson 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 416 KB